Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020
Journal of Hepatology May 18, 2021
Mallet V, Beeker N, Bouam S, et al. - The present study was performed to evaluate the outcomes of all Covid-19 adult inpatients in France, in 2020. Adjusted odds ratios were calculated to assess the relationships between chronic liver disease, alcohol use disorders, mechanical ventilation, and day-30, in-hospital, mortality. They examined the outcomes, including mechanical ventilation and day-30 mortality, of all Covid-19 adults (N=259,110), discharged from acute and post-acute care, private and public hospitals, in France in 2020. The risk of Covid-19 death was increased in chronic liver disease in France in 2020. The findings reveal that therapeutic effort limitation may have contributed to the Covid-19 death of patients with a liver-related complication or with alcohol use disorders.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries